TY - JOUR
T1 - Fine mapping of 14q24.1 breast cancer susceptibility locus
AU - Lee, Phoebe
AU - Fu, Yi-Ping
AU - Figueroa, Jonine D
AU - Prokunina-Olsson, Ludmila
AU - Gonzalez-Bosquet, Jesus
AU - Kraft, Peter
AU - Wang, Zhaoming
AU - Jacobs, Kevin B
AU - Yeager, Meredith
AU - Horner, Marie-Josèphe
AU - Hankinson, Susan E
AU - Hutchinson, Amy
AU - Chatterjee, Nilanjan
AU - Garcia-Closas, Montserrat
AU - Ziegler, Regina G
AU - Berg, Christine D
AU - Buys, Saundra S
AU - McCarty, Catherine A
AU - Feigelson, Heather Spencer
AU - Thun, Michael J
AU - Diver, Ryan
AU - Prentice, Ross
AU - Jackson, Rebecca
AU - Kooperberg, Charles
AU - Chlebowski, Rowan
AU - Lissowska, Jolanta
AU - Peplonska, Beata
AU - Brinton, Louise A
AU - Tucker, Margaret
AU - Fraumeni, Joseph F
AU - Hoover, Robert N
AU - Thomas, Gilles
AU - Hunter, David J
AU - Chanock, Stephen J
PY - 2012/3
Y1 - 2012/3
N2 - In the National Cancer Institute Cancer Genetic Markers of Susceptibility (CGEMS) genome-wide association study of breast cancer, a single nucleotide polymorphism (SNP) marker, rs999737, in the 14q24.1 interval, was associated with breast cancer risk. In order to fine map this region, we imputed a 3.93 MB region flanking rs999737 for Stages 1 and 2 of the CGEMS study (5,692 cases, 5,576 controls) using the combined reference panels of the HapMap 3 and the 1000 Genomes Project. Single-marker association testing and variable-sized sliding-window haplotype analysis were performed, and for both analyses the initial tagging SNP rs999737 retained the strongest association with breast cancer risk. Investigation of contiguous regions did not reveal evidence for an additional independent signal. Therefore, we conclude that rs999737 is an optimal tag SNP for common variants in the 14q24.1 region and thus narrow the candidate variants that should be investigated in follow-up laboratory evaluation.
AB - In the National Cancer Institute Cancer Genetic Markers of Susceptibility (CGEMS) genome-wide association study of breast cancer, a single nucleotide polymorphism (SNP) marker, rs999737, in the 14q24.1 interval, was associated with breast cancer risk. In order to fine map this region, we imputed a 3.93 MB region flanking rs999737 for Stages 1 and 2 of the CGEMS study (5,692 cases, 5,576 controls) using the combined reference panels of the HapMap 3 and the 1000 Genomes Project. Single-marker association testing and variable-sized sliding-window haplotype analysis were performed, and for both analyses the initial tagging SNP rs999737 retained the strongest association with breast cancer risk. Investigation of contiguous regions did not reveal evidence for an additional independent signal. Therefore, we conclude that rs999737 is an optimal tag SNP for common variants in the 14q24.1 region and thus narrow the candidate variants that should be investigated in follow-up laboratory evaluation.
KW - Breast Neoplasms
KW - Case-Control Studies
KW - Chromosome Mapping
KW - Chromosomes, Human, Pair 14
KW - Female
KW - Genetic Predisposition to Disease
KW - HapMap Project
KW - Haplotypes
KW - Humans
KW - Polymorphism, Single Nucleotide
U2 - 10.1007/s00439-011-1088-4
DO - 10.1007/s00439-011-1088-4
M3 - Article
C2 - 21959381
SN - 0340-6717
VL - 131
SP - 479
EP - 490
JO - Human Genetics
JF - Human Genetics
IS - 3
ER -